Triphase Accelerator Announces Positive Updated Phase 1 Data with TRPH-222 in Non-Hodgkin’s Lymphoma
High response rates: ORR of 54% and a CR rate of 38%Durable responses: ~25 months median duration of response Favourable...
Month: February 2022
CytomX Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Alignment Healthcare to Participate in Two Upcoming Investor Conferences
ORANGE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled...
Dyve Biosciences to Present at the Biocom California Global Life Science Partnering Conference
CAMARILLO, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech company applying its proprietary transdermal...
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
– ARCALYST® (rilonacept) net revenue of $18.7 million in Q4 2021 and $38.5 million in 2021 –– ARCALYST collaboration achieved profitability...
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2021 Financial Results and Business Updates
CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and...
Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical Officer
CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation...
Noema Pharma announces first patient dosed in Phase 2b LibraTN study of mGluR5 inhibitor NOE-101 in trigeminal neuralgia
Study evaluating the efficacy of NOE-101 for management of pain associated with trigeminal neuralgiaBASEL, Switzerland, Feb. 22, 2022 (GLOBE NEWSWIRE)...
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi, M.D., as Vice President, Medical
Dr. Galamidi joins Enlivex after 10 years at Gamida Cell Ltd., where she most recently served as Vice President of...
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
Innovators in the application of multi-omics to drug discovery – including phenomics and genomics – to initiate up to 10...
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address considerable unmet needsCombined pipeline extends...
Avra, Inc. Operating as Springs Rejuvenation (AVRN) Reports a +200% Increase in Revenue Post-Merger
ATLANTA, GA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Springs”), a...
LifeMD, Inc. to Announce Year End 2021 Financial Results and Host Conference Call on Monday, March 7
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced...
GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia
MELBOURNE, Australia, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader...
Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration
– Collaboration includes rights to develop and commercialize ARCALYST® and mavrilimumab in the Asia Pacific Region (excluding Japan) – –...
Statera Biopharma Announces Preliminary Revenue and Financial Results of Fiscal Year ‘21
FORT COLLINS, Colo., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a...
Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO Forum
PHILADELPHIA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company...
Olema Oncology to Present at Cowen 42nd Annual Health Care Conference
SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), announced today that...
Neuronetics Announces Amendment of Credit Facility with SLR Investment Corp.
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
VitalHub Subsidiary Wins ‘Excellence in Data, AI and Automation’ Category at the HTN Now Awards 2022
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce that...
